Ticker Details
Enact Holdings, Inc. The investment seeks long-term capital appreciation. The fund is an actively-managed exchange-traded fund that invests at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from tobacco and alcoholic beverages and companies that derive at least 50% of their net revenue from the marijuana and hemp industry or have at least 50% of their company assets dedicated to lawful research and development of cannabis or cannabinoid-related products. It will invest primarily in U.S. exchange listed equity securities, including common and preferred stock and ADRs.
IPO Date:	September 13, 2021
Sector:	Financial Services
Industry:	Insurance - Specialty
Market Cap:	$6.03B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.30 | 1.05%
Avg Daily Range (30 D):	$0.43 | 1.05%
Avg Daily Range (90 D):	$0.44 | 1.07%

Institutional Daily Volume
Avg Daily Volume:	.21M
Avg Daily Volume (30 D):	.22M
Avg Daily Volume (90 D):	.21M

Trade Size
Avg Trade Size (Sh.):	51
Avg Trade Size (Sh.) (30 D):	34
Avg Trade Size (Sh.) (90 D):	34

Institutional Trades
Total Institutional Trades:	1,215
Avg Institutional Trade:	$1.99M
Avg Institutional Trade (30 D):	$2.78M
Avg Institutional Trade (90 D):	$2.4M
Avg Institutional Trade Volume:	.06M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.01M
Avg Closing Trade (30 D):	$3.13M
Avg Closing Trade (90 D):	$2.69M
Avg Closing Volume:	62.71K

News

Feb 3, 2026 @ 9:15 PM Enact Announces New $500 Million Share Repurchase ... Source: Globe Newswire

Aug 21, 2024 @ 10:40 PM Enact Provides Update on Capital Position Under Ne... Source: N/A

Aug 19, 2024 @ 9:06 PM Enact Re, Ltd. Receives A- Rating from S&P Global ... Source: N/A

Aug 1, 2024 @ 10:45 PM Genworth Financial (GNW) Q2 2024 Earnings Call Tra... Source: The Motley Fool

Jul 15, 2024 @ 2:32 PM Will High Costs Weigh on Marsh & McLennan's (MMC) ... Source: Zacks Equity Research

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$4.54	$1.22	$4.54
Diluted EPS	$4.52	$1.22	$4.52
Revenue	$1.24B	$312.71M	$1.24B
Gross Profit
Net Income / Loss	$674.24M	$177.16M	$674.24M
Operating Income / Loss	$858.84M	$223.09M	$858.84M
Cost of Revenue
Net Cash Flow	$-16.94M	$38.92M	$-16.94M
PE Ratio	9.28